NDC 51672-1402-08 - Calcipotriene and Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1402
- Requested NDC
- 51672-1402-08
- Package NDCs from labels
- 51672-1402-4, 51672-1402-8, 51672-1402-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MINERAL OIL - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-4 | Calcipotriene and Betamethasone Dipropionate | 1 in 1 CARTON | SUSPENSION | 1 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 60 g in 1 BOTTLE | SUSPENSION | 60 | 2 | |
| 51672-1402-8 | Calcipotriene and Betamethasone Dipropionate | 2 in 1 CARTON | SUSPENSION | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1402 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20200904_1d0ab2e6-1ab1-4d3e-ad55-7fa26446f191.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mineral oil | MINERAL OIL | CVS Pharmacy, Inc. | 1183bcbc-51ec-e53a-e063-6394a90af0f2 | 2026-06-26 | Warnings, Adverse reactions | T5L8T28FGP |
| HEMORRHOIDAL | MINERAL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE | CVS PHARMACY, INC | 93482a9b-145b-42d4-96db-599c281a39f1 | 2026-06-10 | Warnings | T5L8T28FGP |
| EELHOE Cuticle Pusher Pen | GLYCERIN | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 52c7f956-a2a1-ae1d-e063-6294a90ab3c2 | 2026-05-27 | Warnings | ZF94AP8MEY |
| Attero | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | Perfero Pharma, Inc. | 328148a1-f32e-47a8-99ec-1614c291a450 | 2026-05-18 | Warnings, Adverse reactions | 143NQ3779B 826Y60901U |
| REFRESH LACRI-LUBE | MINERAL OIL, PETROLATUM | Allergan, Inc. | d232a44b-516d-4cdf-a4e7-c3a9a50dc7af | 2026-05-15 | Warnings | T5L8T28FGP |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | b5291e39-40a0-4362-9281-97f5fb4025d9 | 2026-05-11 | Warnings, Adverse reactions | 826Y60901U |
| BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | Aurobindo Pharma Limited | a4f8db3a-0aed-451c-98ba-c4ce37656792 | 2026-05-04 | Adverse reactions | 826Y60901U |
| Pellix | CALCIPOTRIENE | Perfero Pharma, Inc. | 492ea9cf-0117-4d84-a964-9c0121706ed3 | 2026-05-04 | Warnings, Adverse reactions | 143NQ3779B |
| Mineral Oil | MINERAL OIL | Publix Supermarkets, Inc. | 382a57d1-85bf-480f-9967-f85da2904410 | 2026-04-23 | Warnings | T5L8T28FGP |
| Sernivo | BETAMETHASONE DIPROPIONATE | Primus Pharmaceuticals, Inc. | b1b3d1b0-da9b-11eb-ad76-0800200c9a66 | 2026-04-22 | Warnings, Adverse reactions | 826Y60901U |
| PRENATE DHA | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, FOLIC ACID, LEVOMEFOLATE CALCIUM, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, MAGNESIUM OXIDE AND DOCONEXENT | Avion Pharmaceuticals, LLC | 8f2eca71-9a82-4a19-9206-36a04b865fe1 | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | 7QWA1RIO01 |
| Equaline Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | United Natural Foods, Inc. dba UNFI | a6ed1987-37ad-4bfd-8cea-f03426953f5a | 2026-04-16 | Warnings | T5L8T28FGP |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Sportpharm LLC | 313dde2e-fb82-4786-988b-565d3e003c37 | 2026-04-01 | Warnings, Adverse reactions | 826Y60901U |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals Inc. | 196e24fc-3315-4366-ad40-51b7ea54b211 | 2026-04-01 | Warnings, Adverse reactions | 826Y60901U |
| Hemorrhoidal | LIDOCAINE, MINERAL OIL, PHENYLEPHRINE HCL, WHITE PETROLATUM | Walgreens Co | 3d213ba8-3cbe-11c4-e063-6394a90ae016 | 2026-03-30 | Warnings | T5L8T28FGP |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals, Inc. | 5683885d-461c-4e7e-bbe8-dc231d706192 | 2026-03-19 | Warnings, Adverse reactions | 826Y60901U |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals, Inc. | 54eff1fc-c611-4929-bb44-c1834c08f506 | 2026-03-19 | Warnings, Adverse reactions | 826Y60901U |
| Clotrimazole/Betameth | CLOTRIMAZOLE/BETAMETH | Direct_Rx | 08901233-7d36-e5d9-e063-6394a90af33d | 2026-03-17 | Warnings, Adverse reactions | 826Y60901U |
| Mineral Oil | MINERAL OIL | Chain Drug Marketing Association | 3bfdad9c-ac58-4e92-b952-555e8a8351cd | 2026-02-27 | Warnings, Adverse reactions | T5L8T28FGP |
| Mineral Oil | MINERAL OIL | Better Living Brands, LLC | 7f2f1b30-497a-4c53-accc-8455169b17b3 | 2026-02-24 | Warnings, Adverse reactions | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.